Molecular Testing in Lung Cancer: Recommendations and Update

Area of Science:

• Oncology
• Pathology
• Molecular Diagnostics

Background:

• Molecular testing is increasingly adopted in lung cancer management.
• Key indications include staging and predicting response to targeted therapies.
• Both tissue specimens and blood-based testing are vital, with cytology also playing a role.

Purpose of the Study:

• To highlight the importance of optimizing molecular testing strategies in lung cancer.
• To emphasize the role of pathologists in ensuring timely and complete assessments.
• To address challenges associated with limited tissue samples.

Main Methods:

• Review of current practices in lung cancer molecular testing.
• Discussion of diagnostic algorithms and test selection.
• Consideration of strategies for limited tissue specimens.

Main Results:

• Molecular testing is essential for personalized lung cancer treatment.
• Pathologists play a critical role in test optimization and interpretation.
• Effective strategies are needed to maximize information from limited tissue.

Conclusions:

• Optimizing reflex testing and utilizing stage-based algorithms are crucial for pathologists.
• When tissue is limited, prioritizing common, mutually exclusive alterations maximizes diagnostic yield.
• Avoiding repeat biopsies through strategic testing is a key objective.